Journal of Neurology, Neurosurgery and Psychiatry

is a leading international journal publishing the latest research and reviews on all areas of neurological sciences.

Impact Factor: 13.654
Citescore:15.1
All metrics >>

Journal of Neurology, Neurosurgery and Psychiatry is a Plan S compliant Transformative Journal.

Journal of Neurology, Neurosurgery and Psychiatry (JNNP)'s ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson's disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. With early online publication, regular podcasts and an immense archive collection (with the longest half-life of any journal in clinical neuroscience), JNNP is a trail-blazer and not a follower.

Subscribers to JNNP also have access to Practical Neurology and the Journal of NeuroInterventional Surgery.

JNNP publishes regular podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify.

Editor in Chief: Dr Karen Furie, Warren Alpert Medical School of Brown University
Editorial Board

Current Issue

Authors

JNNP accepts submissions of a wide range of article types, including review articles and original research.

The Author Information section provides specific article requirements to help you turn your research into an article suitable for JNNP.

Information is also provided on editorial policies and open access.

Author information Submit a paper

Latest Articles

Editorial commentaries:

Tipping the scales towards routine APOE genotyping

14 August 2023

General neurology:

APOE genotypes modify the obesity paradox in dementia

14 August 2023

Spinal cord injury:

Nitrous oxide-induced myeloneuropathy: a case series

14 August 2023

Multiple sclerosis:

Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020

14 August 2023

Multiple sclerosis:

Association of serum neurofilament light with microglial activation in multiple sclerosis

14 August 2023

Most Read Articles

Cognition:

Timing of physical activity across adulthood on later-life cognition: 30 years follow-up in the 1946 British birth cohort

21 February 2023

General neurology:

Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension

5 May 2023

Neuropsychiatry:

What is brain fog?

14 March 2023

Neuropsychiatry:

Functional neurological disorder is a feminist issue

6 April 2023

Letter:

Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study

8 March 2023

Editor's Choice

General neurology:

APOE genotypes modify the obesity paradox in dementia

6 July 2023

General neurology:

Recent advances in neuroanatomy: the myotome update

18 January 2023

Cerebrovascular disease:

Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging

3 March 2023

Neurodegeneration:

Elevated plasma p-tau181 levels unrelated to Alzheimer’s disease pathology in amyotrophic lateral sclerosis

3 April 2023

Occasional essay:

A roadmap to ALS prevention: strategies and priorities

23 January 2023

COVID-19

PostScript:

Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study

8 March 2023

PostScript:

Correspondence on functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines

7 April 2023

Multiple sclerosis:

Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?

21 July 2023

PostScript:

Humoral and cellular responses to SARS-CoV-2 vaccination in patients with autoantibody-mediated neuroimmunology

3 January 2023

Multiple sclerosis:

Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses

25 April 2023

Altmetrics

Timing of physical activity across adulthood on later-life cognition: 30 years follow-up in the 1946 British birth cohort
21 February 2023

Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials
20 July 2020

Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
25 May 2021

Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study
5 November 2020

Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study
23 January 2023

Podcasts

Featured Video

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease

1 July 2022

Repurposing of established noradrenergic drugs is most likely to offer effective treatment in Alzheimer’s disease for general cognition and apathy. However, several factors should be considered before designing future clinical trials. These include targeting of appropriate patient subgroups and understanding the dose effects of individual drugs and their interactions with other treatments to minimise risks and maximise therapeutic effects.

Find out more

Related Journals

Journal of Neurology, Neurosurgery and Psychiatry

Authors

Latest Articles

Most Read Articles

Editor's Choice

COVID-19

Altmetrics

Podcasts

Featured Video

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease

Related Journals

BMJ Neurology Open

General Psychiatry

Journal of NeuroInterventional Surgery

Practical Neurology

Stroke and Vascular Neurology